This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Zoom Rx recently polled HCPs and found 78% of physicians want to maintain some contact with pharmareps. The most desired information doctors now want is about patient assistance programs, with 49% saying they want pharmareps to provide that information. Where to start?
Back to HCP’s…digitization can’t replace the relationships that pharmareps and MLS people build with doctors. For HCP marketing it will be PART of the mix but won’t yet replace in-person reps. To them, an HCP is just a “step” to an Rx so naturally telehealth is an advantage.
Omnichannel is the latest buzzword-making rounds within pharma, but omnichannel has no relevance if your message is too promotional or is irrelevant to your audience. 68% of HCPs indicate webinars or webcasts as their most preferred channel to receive information. The channel IS essential but not as important as your message.
The one-size-fits-all approach will no longer work, and pharma companies will have to invest in greater personalization at scale and build better content development and operations capabilities. INSIGHT: This study shows that HCPs are demanding more from pharma, but these data points should not be used across all specialties.
How Drug Access Programs Shape My Role As a pharmarep, I’ve seen the real, transformative impact of these programs. For pharmareps, the opportunity lies in being proactive – providing clear information, assisting with enrollment processes, and ensuring smooth communication between all stakeholders.
Here are some common issues that I find: 1ne: The click-stream research shows that people go to many other health websites to collect information after leaving a pharma product website. Health care professionals are finding that pharma sites don’t provide enough answers and are using HCP-targeted sites more and more.
Unlike traditional consumer marketing, pharma marketing requires a strategic approach that balances compliance, education, and innovation. Marketers must ensure that HCPs receive valuable scientific information while also providing patients with easy-to-understand, accurate health resources.
Why This Hits Close to Home for PharmaReps As someone in pharma sales, this problem feels personal. For those of us in pharma sales, it’s about being proactive – educating our clients, staying informed about the latest counterfeiting tactics, and ensuring our products are always associated with quality and reliability.
The resulting data offer a view into physician information needs at two critical junctures—during diagnosis and treatment selection. “We physicians are running into challenges around the diagnosis and treatment phase of specific diseases, and so express a need for information that will help them in each phase of the disease progression.”.
Pharma companies are also helping patients understand where they can access labs, infusion centers, or imaging centers and offering solutions to HCPs and their practices so they can more easily afford and keep stock of therapies. And, in fact, 61% said they are interacting with pharma sales reps more during COVID-19 than they did before.
Some of the questions we quizzed the physicians with focused on their thoughts around interactions with pharmareps. And the responses suggest an increasingly difficult future for the reps working in the EU5 markets. Fortunately, a lot of positive news is also coming out of our European research and the corresponding report.
ACTO LAICA RepAssist by ACTO is the first GenAI Knowledge Assistant built specifically for Life Sciences and is designed to improve healthcare provider (HCP) interactions by providing pharma field reps with instant access to approved clinical and product information.
A decade ago, pharmareps could easily book in-person meetings with doctors, build lasting relationships, and crush their sales quotas. We have yet to talk about the increased level of competition that modern reps have to deal with. We have yet to talk about the increased level of competition that modern reps have to deal with.
On the physician front, the core technology that is powering meetings between a physician and patient is also making engagement between a pharmarep and a physician possible. Similar to the spike in the use of telemedicine between patients and physicians, there has been a spike in virtual detailing between pharmareps and physicians.
Pharmaceutical representatives (pharmareps) are facing new challenges as a result of these transformations that have drastically altered the pharmaceutical sales landscape. Essential Competencies in Pharmaceutical Sales First, let’s review the competencies of a successful sales rep in pharma.
Enhancing communication across care teams and improving multi-site operations with features such as video conferencing, a digital whiteboard and RxVantage calendar integration to more efficiently connect healthcare providers with relevant pharmareps.
That’s a lot of information. Periodic observation, coaching sessions, client feedback, and role-play exercises often fail to explain why some pharmareps consistently meet and exceed management expectations while other equally knowledgeable reps do not.
How can we ensure that vital prescription information reaches patients when they need it? Information shared should be crafted to align with where they are in the journey; new patients getting one message and existing patients another. These strategies also reduce the burden on the HCP to look for patient support information.
I remember my first training session vividly – it was intense, informative, and somewhat intimidating. As a male rep entering this competitive field, I felt the pressure to absorb every bit of information and perfect my pitch to stand out. Back then, training was heavily focused on product knowledge.
For pharmareps, understanding the market and staying prepared with stock availability is key to turning these breaks into long-term gains. This situation underscores the critical role of pharma sales reps in maintaining strong relationships with healthcare providers.
While digital channels are gaining traction, there’s an interesting paradox HCPs still place immense value on face-to-face interactions with pharmareps. The pharmaceutical industry is going through a transformative period when it comes to engaging with healthcare providers (HCPs).
This engagement is continuing to remain high, with evolving requirements and preferences of healthcare practitioners (HCPs) in the ways they engage with pharmareps and medical science liaisons (MSLs) through virtual communications. Five steps to closing the CX gap with HCPs and Patients.
Pharmaceutical sales representatives (commonly known as “pharmareps” or “drug reps”) are responsible for promoting and educating healthcare providers about their company’s products, with the ultimate goal of increasing product sales and market share.
Definition and Role A pharmaceutical sales representative , colloquially known as a pharmarep, is a professional who markets and promotes prescription drugs to medical providers.
Imagine what a pharmarep will look like in 10 years. We want to put what they need right at their fingertips to get more done in this information-rich environment without getting lost or distracted in the software. Will they still be out driving all the time? Maybe they’ll just be using their phones.
From cutting-edge training techniques that break the mold, to the latest industry trends making waves, and the career development hacks every pharmarep should know – we've got it all covered. This trend demands a deeper level of scientific knowledge and the ability to convey this information in a clear, relatable manner.
As pharmareps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. On average, HCPs viewed this medication’s approved information for approximately 32 seconds. THE CHALLENGE.
Meanwhile, 90% of patients believe their primary care physician will give them solid information to help them and their disorder. Just leaving an ad on the wall or counter in the hope the patient will subliminally absorb the information is not going to work. Gimmicks like exam table paper do not work either.
Others want to have access to information on demand, at their fingertips. To cater to all of these preferences at the same time, we are seeing Pharma teams turn to online educational platforms that can be used to host both video/audio/visual content, on-demand webinar recordings, and live virtual meetings.
Finally, diving into the essentials of pursuing a career in electrophysiology med device sales, Keila highlights the need for a genuine curiosity to understand complex information and adaptability in this dynamic field. We had pharmareps come through. You have to have the interest and mindset to handle the complex information.
Let’s get into that space because that’s a space that there isn’t enough information about as a whole. I would say it’s equivalent probably to a pharmarep. Is it the same as in any medical sales rep if you want the manager and then if you want the executive, or are they different?
A majority of HCPs want to receive relevant information on their own times and terms. A recent Sermo survey indicated that nearly two-thirds of responders changed their perception of medications or treatment options based on information obtained on social media. million self-identified HCPs on the platform to pharma marketers.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content